Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2.2
Condensed Consolidated Balance Sheets - USD ($)
Oct. 31, 2022
Jul. 31, 2022
Current assets    
Cash and cash equivalents $ 5,729,691 $ 12,299,740
Prepaid expenses and other current assets 2,903,468 2,932,731
Total Current Assets 8,633,159 15,232,471
Property and equipment, net 933,701 978,614
Intangible assets, net 361,059 378,529
Operating lease right-of-use assets 3,931,083 4,665,515
Other long-term assets 579,960 623,239
Total Assets 14,438,962 21,878,368
Current liabilities    
Accounts payable and accrued liabilities 4,802,456 4,208,222
Accrued compensation related 468,618 376,977
Operating lease liabilities 978,570 1,111,571
Note payable 659,870 936,558
Total Current Liabilities 6,909,514 6,633,328
Operating lease liabilities, net of current portion 3,513,897 4,126,636
Liability under co-promotion agreement - related party 5,000,000 5,000,000
Total Liabilities 15,423,411 15,759,964
Stockholders’ Equity (Deficit)    
Common stock authorized – 4,545,455 common shares with a par value of $0.0001 as of October 31, 2022 and July 31, 2022, common stock issued and outstanding – 1,790,741 and 1,790,051 common shares as of October 31, 2022 and July 31, 2022, respectively 179 179
Additional paid-in capital 288,767,020 288,236,945
Warrants issued and outstanding – 75,897 and 77,554 warrants as of October 31, 2022 and July 31, 2022, respectively 3,368,509 3,591,734
Accumulated other comprehensive income 898,906 247,211
Accumulated deficit (294,019,063) (285,957,665)
Total Stockholders’ Equity (Deficit) (984,449) 6,118,404
Total Liabilities and Stockholders’ Equity (Deficit) $ 14,438,962 $ 21,878,368